Emfizatamab Biosimilar - Anti-CD3e,CD19,CD274,TNFRSF9 mAb - Research Grade, Monoclonal
Catalog Number:
PTG-PX-TA1893-100
| Article Name: |
Emfizatamab Biosimilar - Anti-CD3e,CD19,CD274,TNFRSF9 mAb - Research Grade, Monoclonal |
| Biozol Catalog Number: |
PTG-PX-TA1893-100 |
| Supplier Catalog Number: |
PX-TA1893-100 |
| Alternative Catalog Number: |
PTG-PX-TA1893-100 |
| Manufacturer: |
ProteoGenix |
| Category: |
Antikörper |
| Species Reactivity: |
Human |
| Alternative Names: |
Anti-CD19, Anti-PD-L1, Anti-CD137, GNC 038, GNC-038, GNC038, CAS: 2559704-23-1 |
| Clonality: |
Monoclonal |
| UniProt: |
P15391 |
| Buffer: |
0.01M PBS, pH 7.4. |
| Expression System: |
Eukaryotic expression |
| Target: |
CD19 & PD-L1 & CD3E & CD137 |